Position history for FEDERATED HERMES, INC.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
FEDERATED HERMES, INC. previously held 0 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$86.6M
Total Shares Change
-2.1M
Other major holders of RARE: Capital Research Global Investors, Capital International Investors
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $22.78 |
0 |
| 2025-Q3 | Decreased | 496,060 | -75.8% | $14.9M | 0.0% | $30.36 | 0 |
| 2025-Q2 | Decreased | 2M | -0.3% | $74.5M | 0.1% | $36.52 | 0 |
| 2025-Q1 | Increased | 2.1M | +0.3% | $74.4M | 0.2% | $37.82 | 35 |
| 2024-Q4 | Decreased | 2M | -2.9% | $86.2M | 0.2% | $42.27 | 0 |
| 2024-Q3 | Increased | 2.1M | +0.2% | $117.2M | 0.3% | $54.43 | 36 |
| 2024-Q2 | Increased | 2.1M | +8.7% | $86.6M | 0.2% | $41.10 | 39 |